- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Riptide signs security deal with Intel for radiology
Riptide signs security deal with Intel for radiologyRiptide Technologies plans to offer advanced Internet security to hospital radiology departments and imaging centers following an agreement with Intel Internet Authentication Services (IAS).
Riptide signs security deal with Intel for radiology
Riptide Technologies plans to offer advanced Internet security to hospital radiology departments and imaging centers following an agreement with Intel Internet Authentication Services (IAS). Under terms of the deal, Riptide and Intel IAS will work together to integrate Intels real-time physician identity authentication services into Riptides Internet-based Advanced Radiology Image and Information System (ARIIS). The result should enhance referring physicians online and remote access to images, while maintaining security and patient privacy. ARIIS is a Web-based system that combines RIS, PACS, report generation, and charge-capture capabilities in an open-architecture XML design.
- Search Again
- Return To HNN Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
